{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:19:42Z","timestamp":1740140382470,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Embryo selection in Familial amyloid polyneuropathy eradicates the disease, but the widespread application of preimplantation genetic testing (PGT) for this monogenic disease still requires greater political and clinical commitment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>Familial amyloid polyneuropathy is a fatal, chronic, hereditary autosomal dominant neurodegenerative disorder caused by a single nucleotide mutation in the transthyretin gene. The disease courses with infertility, cachexia, blindness, renal failure, cardiovascular collapse, and premature death. Treatments include organ transplantation, transthyretin stabilizers, silencers and gene editing. Unfortunately, these treatments only improve the patient\u2019s quality of life.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Short conclusion<\/jats:title>\n                <jats:p>The application of PGT would prevent the disease, the birth of children with this devastating disease and the enormous health costs associated. For PGT to become the first reproductive option for patients, a paradigm shift in governmental, social and medical policies is necessary.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12978-022-01491-x","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:03:26Z","timestamp":1668816206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preimplantation genetic testing for familial amyloid polyneuropathy"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-3290","authenticated-orcid":false,"given":"M\u00e1rio","family":"Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"3","key":"1491_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C. A peculiar form of peripheral neuropathy: familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75(3):408\u201327. https:\/\/doi.org\/10.1093\/brain\/75.3.408.","journal-title":"Brain"},{"issue":"7","key":"1491_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","volume":"15","author":"D Adams","year":"2019","unstructured":"Adams D, Koike H, Slama M, Coelho T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 2019;15(7):387\u2013404. https:\/\/doi.org\/10.1038\/s41582-019-0210-4.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"1491_CR3","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","volume":"268","author":"D Adams","year":"2020","unstructured":"Adams D, Ando Y, Beir\u00e3o JM, Coelho T, Gertz MA, Gillmore JD, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2020;268(6):2109\u201322. https:\/\/doi.org\/10.1007\/s00415-019-09688-0.","journal-title":"J Neurol"},{"issue":"1","key":"1491_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1172\/JCI111390","volume":"74","author":"MJ Saraiva","year":"1984","unstructured":"Saraiva MJ, Birken S, Costa PP, Goodman DS. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest. 1984;74(1):104\u201319. https:\/\/doi.org\/10.1172\/JCI111390.","journal-title":"J Clin Invest"},{"issue":"12","key":"1491_CR5","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.3390\/ijms20122982","volume":"20","author":"GY Park","year":"2019","unstructured":"Park GY, Jamerlan A, Shim KH, An SSA. Diagnostic and treatment approaches involving transthyretin in amyloidogenic diseases. Int J Mol Sci. 2019;20(12):2982. https:\/\/doi.org\/10.3390\/ijms20122982.","journal-title":"Int J Mol Sci"},{"key":"1491_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.brainres.2010.06.017","volume":"1348","author":"T Murakami","year":"2000","unstructured":"Murakami T, Ohsawa Y, Zhenghua L, Yamamura K-i, Sunada Y. The Transthyretin gene is expressed in Schwann cells of peripheral nerves. Brain Res. 2000;1348:222\u20135. https:\/\/doi.org\/10.1016\/j.brainres.2010.06.017.","journal-title":"Brain Res"},{"issue":"5","key":"1491_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.pneurobio.2003.11.002","volume":"71","author":"MM Sousa","year":"2003","unstructured":"Sousa MM, Saraiva MJ. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol. 2003;71(5):385\u2013400. https:\/\/doi.org\/10.1016\/j.pneurobio.2003.11.002.","journal-title":"Prog Neurobiol"},{"issue":"31","key":"1491_CR8","doi-asserted-by":"publisher","first-page":"21998","DOI":"10.1074\/jbc.M602302200","volume":"281","author":"PF Teixeira","year":"2006","unstructured":"Teixeira PF, Cerca F, Santos SD, Saraiva MJ. Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J Biol Chem. 2006;281(31):21998\u20132003. https:\/\/doi.org\/10.1074\/jbc.M602302200.","journal-title":"J Biol Chem"},{"issue":"2","key":"1491_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5935\/1518-0557.20170025","volume":"21","author":"RA Lopes","year":"2017","unstructured":"Lopes RA, Coelho T, Barros A, Sousa M. Corino de Andrade disease: mechanisms and impact on reproduction. JBRA Assist Reprod. 2017;21(2):105\u201314. https:\/\/doi.org\/10.5935\/1518-0557.20170025.","journal-title":"JBRA Assist Reprod"},{"issue":"3","key":"1491_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/13506129.2019.1627312","volume":"26","author":"I Concei\u00e7\u00e3o","year":"2019","unstructured":"Concei\u00e7\u00e3o I, Coelho T, Rapezzi C, Parman Y, Obici L, Gal\u00e1n L, et al. Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progression. Amyloid. 2019;26(3):103\u201311. https:\/\/doi.org\/10.1080\/13506129.2019.1627312.","journal-title":"Amyloid"},{"issue":"21","key":"1491_CR11","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","volume":"66","author":"NA Gertz","year":"2015","unstructured":"Gertz NA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Amer Coll Cardiol. 2015;66(21):2451\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2015.09.075.","journal-title":"J Amer Coll Cardiol"},{"issue":"6","key":"1491_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore JD, Gane E, Taubel J, Kao J, Fontana M, Maitland ML, et al. CRISP-Cas9 in vivo gene editing for transthyretin amyloidosis. N Engl J Med. 2021;385(6):493\u2013502. https:\/\/doi.org\/10.1056\/NEJMoa2107454.","journal-title":"N Engl J Med"},{"key":"1491_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/TCRM.S219979","volume":"16","author":"M Luigetti","year":"2020","unstructured":"Luigetti M, Romano A, Di Paolantonio A, Bisogni G, Sabatelli M. Diagnosis and treatment of hereditary transthyretin amyloidosis (hATTR) polyneuropathy: current perspectives on improving patient care. Ther Clin Risk Manag. 2020;16:109\u201323. https:\/\/doi.org\/10.2147\/TCRM.S219979.","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"1491_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/pd.250","volume":"21","author":"F Carvalho","year":"2001","unstructured":"Carvalho F, Sousa M, Fernandes S, Silva J, Saraiva MJ, Barros A. Preimplantation genetic diagnosis for familial amyloidotic polyneuropathy (FAP). Prenat Diagn. 2001;21(12):1093\u20139. https:\/\/doi.org\/10.1002\/pd.250.","journal-title":"Prenat Diagn"},{"issue":"1","key":"1491_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.rbmo.2017.09.010","volume":"36","author":"R Lopes","year":"2018","unstructured":"Lopes R, Sousa M, Silva J, Cunha M, Oliveira C, Teixeira da Silva J, et al. Clinical outcomes after preimplantation genetic diagnosis of patients with Corino de Andrade disease (familial amyloid polyneuropathy). Reprod Biomed Online. 2018;36(1):39\u201346. https:\/\/doi.org\/10.1016\/j.rbmo.2017.09.010.","journal-title":"Reprod Biomed Online"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-022-01491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-022-01491-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-022-01491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T12:05:37Z","timestamp":1668859537000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-022-01491-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1491"],"URL":"https:\/\/doi.org\/10.1186\/s12978-022-01491-x","relation":{},"ISSN":["1742-4755"],"issn-type":[{"type":"electronic","value":"1742-4755"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Publications under the present institution are approved by the University Hospital Ethics Committee, with authorization number Project: 2019\/CE\/P017 (266\/CETI\/ICBAS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}